Wall Street Journal -- Pfizer Inc. and Sanofi-Aventis SA said that Japanese health authorities cleared the way for the companies to resume sales of widely used childhood vaccines Prevnar and ActHIB, whose use had been suspended amid safety concerns.
Wall Street Journal -- Pfizer Inc. and Sanofi-Aventis SA said that Japanese health authorities cleared the way for the companies to resume sales of widely used childhood vaccines Prevnar and ActHIB, whose use had been suspended amid safety concerns.
